Chemomab Therapeutics (CMMB) Short-term Investments (2012 - 2026)
Chemomab Therapeutics (CMMB) reported Short-term Investments of $688,000 for Q2 2026, down 82.4% from $3.92 million a year earlier and down 67.8% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Short-term Investments (2012 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics posted Short-term Investments of $2.8 million, down 65.8% from FY2024.
- Short-term Investments has declined for three consecutive years, with a three-year compound annual growth rate of -52.6% (FY2022 to FY2025).
- By year, Short-term Investments came in at $8.2 million in FY2024 (-21.9%), $10.49 million in FY2023 (-60.2%) and $26.37 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Short-term Investments in data going back to Q4 2022.
- Year over year, Short-term Investments has now declined in each of the last seven quarters, with an average decline of 46.8% over the last eight quarters.
- The high point for year-over-year Short-term Investments in five years was Q3 2024 (growth of 4.6%); the low point was Q2 2026 (a decline of 82.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.14 million (Q1 2026), $2.8 million (Q4 2025) and $3.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Chemomab Therapeutics | 7.77 Mn | -27.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 688,000.00 |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 3.92 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 8.20 Mn |
| Sep 30, 2024 | 12.78 Mn |
| Jun 30, 2024 | 7.69 Mn |
| Mar 31, 2024 | 11.21 Mn |
| Dec 31, 2023 | 10.49 Mn |
| Sep 30, 2023 | 12.22 Mn |
| Jun 30, 2023 | 16.21 Mn |
| Dec 31, 2022 | 26.37 Mn |
| Dec 31, 2012 | 565,085.48 |
| Sep 30, 2012 | 770,019.23 |
API Access
Chemomab Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();